Mechanistically, FASN binds to and upregulates HIF1α, inhibits ubiquitination, and promote nuclear translocation, thereby upregulating the downstream target SLC7A11 and subsequently reducing accumulation of lipid peroxidases, inhibiting HCC ferroptosis, and promoting sorafenib resistance in HCC. This evidence concerns the gene HIF1A and hepatocellular carcinoma.